University at Buffalo spinoff Cytocybernetics is developing a high-tech tool called CyberQ to rapidly assess whether or not investigational COVID-19 drugs have arrhythmogenic properties that can result in sudden cardiac death.
When a corporation’s earnings are steady, its board of directors is more likely to fire their CEO after a bad earnings period, according to new research from the University at Buffalo School of Management.
The U.S. government is good at identifying and funding successful entrepreneurial ventures, according to new research from the University at Buffalo School of Management.